Abstract:Neuraminidase (NA) is a pivotal surface enzyme and a key therapeutic target in combating the influenza A virus. Its evolution can lead to potential zoonotic transmission, seasonal epidemics, and the emergence of drug-resistant mutants. To gain comprehensive insights into the mutational effects and drug resistance profiles of NA, we employed a high-throughput profiling system to quantify the replication capacity of NA mutants at the single-nucleotide level in mouse lung tissues. The fitness of NA mutants is generally correlated with natural mutation occurrence and is constrained by both the requirement to maintain protein stability and NA function. Leveraging this system, we profiled the drug resistance to the three most commonly used neuraminidase inhibitors (NAIs): zanamivir, oseltamivir, and peramivir. In addition to identifying previously reported drug resistance mutations, we validated novel mutants. Notably, we identified an allosteric mutation that confers resistance to all three drugs, which may affect drug binding by interfering with the tetramerization of NA. Moreover, the fitness cost associated with drug-resistant mutations may limit their widespread dissemination. In summary, we provided a parallel characterization of NA's fitness and drug resistance landscape in an context, which may guide the rational selection of antiviral drugs for optimal therapeutic efficacy and second-generation NAI development. IMPORTANCE NA is a crucial surface antigen and drug target of influenza A virus. A comprehensive understanding of NA's mutational effect and drug resistance profiles is essential for comprehending the evolutionary constraints and making informed choices regarding drug selection to combat resistance in clinical settings. In the current study, we established an efficient deep mutational screening system in mouse lung tissues and systematically evaluated the fitness effect and drug resistance to three neuraminidase inhibitors of NA single-nucleotide mutations. The fitness of NA mutants is generally correlated with a natural mutation in the database. The fitness of NA mutants is influenced by biophysical factors such as protein stability, complex formation, and the immune response triggered by viral infection. In addition to confirming previously reported drug-resistant mutations, novel mutations were identified. Interestingly, we identified an allosteric drug-resistance mutation that is not located within the drug-binding pocket but potentially affects drug binding by interfering with NA tetramerization. The dual assessments performed in this study provide a more accurate assessment of the evolutionary potential of drug-resistant mutations and offer guidance for the rational selection of antiviral drugs.

Drug-Resistant and Genetic Evolutionary Analysis of Influenza Virus from Patients During the 2013 and 2014 Influenza Season in Beijing.

Surveillance of influenza A virus in Beijing from 2009-2010

Molecular epidemiology and evolution of influenza A and B viruses during winter 2013-2014 in Beijing, China

Analysis on Influenza Surveillance in Nanping in 2009

Molecular Evolution and Characterization of Hemagglutinin and Neuraminidase of Influenza A(H1N1)pdm09 Viruses Isolated in Beijing, China, During the 2017–2018 and 2018–2019 Influenza Seasons

Evolutionary, Genetic, Structural Characterization and Its Functional Implications for the Influenza A (H1N1) Infection Outbreak in India from 2009 to 2017.

Emergency Surveillance of Influenza During 2009 in the Chinese City of Qingdao

Phylogenetic Analysis of HA and NA Genes of Influenza A Viruses in Immunosuppressed Inpatients in Beijing During the 2018–2020 Influenza Seasons

Whole-genome evolution of influenza B viruses prevalent in Qingdao from 2006 to 2011

Variation characteristics of hemagglutinin and neuraminidase of 54 influenza A strains from Beijing during 2012 to 2014

Molecular epidemiology and evolution of A(H1N1)pdm09 and H3N2 virus during winter 2012–2013 in Beijing, China

Genomic Analyses Uncover Evolutionary Features of Influenza A/H3N2 Viruses in Yunnan Province, China, from 2017 to 2022

Phylogenetic Analysis of HA and NA Genes and Clinical Characteristics of the Co-Occurring Mutations in HA and NA of Influenza A(H1N1)pdm09 Viruses During 2015-2017 in Beijing, China

Analysis of etiological characteristics of influenza B virus in Songjiang district, Shanghai from 2017 to 2020

Genetic characterization and whole-genome sequencing-based genetic analysis of influenza virus in Jining City during 2021–2022

Deep mutational scanning of influenza A virus neuraminidase facilitates the identification of drug resistance mutations in vivo .

The Global Trend of Drug Resistant Sites in Influenza A Virus Neuraminidase Protein from 2011 to 2020

Clinical characteristics of outpatients with influenza-B-associated pneumonia and molecular evolution of influenza B virus in Beijing, China, during the 2021–2022 influenza season

Viral Genome and Antiviral Drug Sensitivity Analysis of Two Patients from a Family Cluster Caused by the Influenza A(H7N9) Virus in Zhejiang, China, 2013.

Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011.

Phylogenetic analysis and antiviral surveillance of influenza A viruses in Qingdao form 2005 to 2011